Pacemakers have saved a lot of lives over the years by helping to regulate the heartbeats of those with arrhythmia. The problem, however, is that those pacemakers run on batteries that have a tendency to run out of juice after a while. As a result, patients have to undergo an invasive procedure every once in a while in order to stay alive. By utilizing the technology that allows wristwatches to function, this problem may have finally been addressed.
The researchers responsible for the discovery are Andreas Haeberlin and Adrian Zurbuchen from the University of Bern and the University of Michigan, Futurism reports. The method that the pair proposed basically involves initiating a cycle between the pacemaker and the heart, where the heartbeat will give the pacemaker power via kinetic energy and the pacemaker will give the heart assistance in order to maintain a consistent rhythm.
By setting the system up like this, it creates a loop where the pacemaker is continuously powered and the heartbeat is continuously maintained to have a normal pace. Basically, the researchers just made the heart the battery for the thing that’s keeping it working. A symbiotic relationship, in a sense.
Aside from pacemakers, this discovery could potentially also have an impact on other implanted devices, TechXplore reports. These could include defibrillators or electrical stimulators that keep important organs from ceasing to function. This is a solution that addresses one of the biggest problems involved in implanted devices.
"Repeated battery replacement procedures can be avoided by extending the implants lifespan, which is the goal of energy harvesting concepts,” the Abstract of the paper reads. This reduces the risk of complications for the patient and may even reduce device size. The continuous and powerful contractions of a human heart ideally qualify as a battery substitute."


Coupang Apologizes After Massive Data Breach Affecting 33.7 Million Users
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Baidu Cuts Jobs as AI Competition and Ad Revenue Slump Intensify
Nexperia Urges China Division to Resume Chip Production as Supply Risks Mount
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Apple Appoints Amar Subramanya as New Vice President of AI Amid Push to Accelerate Innovation
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds 



